Louisiana Diabetes Profile

Diagnosed diabetes is prevalent across all 50 states and Washington, DC. People with diabetes are at high risk of heart disease, stroke, and other serious complications, such as kidney failure, blindness, and amputation of a toe, foot, or leg. CDC’s Division of Diabetes Translation (DDT) focuses on preventing type 2 diabetes, reducing diabetes complications and disability, and reducing diabetes-related disparities, which are differences in health across geographic, racial, ethnic, and socioeconomic groups.

View another state
Key Metrics in Louisiana
$2M

Fiscal Year 2022 Funding

Nationally: $88.5M
500.8K

Total Diabetes Cases (Prevalence)

Nationally: 28.5M
32.5K

New Diabetes Cases (Incidence)

Nationally: 1.4M
7.7%
Notified of Prediabetes
Nationally: 8.8%
4.7M
State Population
Nationally: 328.2M
$4.2B
per year in direct medical costs attributed to diabetes
Nationally: $237B
$1.5B
per year in indirect costs attributed to diabetes
Nationally: $90B
Does Louisiana Have a Diabetes Action Plan?
Yes
(28 States Nationally)
DDT Direct Funding to Louisiana
Louisiana Program Activities
National Diabetes Prevention Program (National DPP)
27
CDC-recognized organizations offering the lifestyle change program
(2.1K Nationally)
3
Medicare Diabetes Prevention Program suppliers
(288 Nationally)
8.5K
Participants enrolled in the National DPP lifestyle change program
(583K Nationally)
Louisiana Medicaid program does not have some level of Medicaid coverage for the National DPP lifestyle change program
Diabetes Self-Management Education and Support (DSMES)
44
Recognized/accredited DSMES service providers
(2.1K Nationally)
22.5K
People with diabetes with at least one encounter at a recognized/accredited DSMES service
(929K Nationally)
Louisiana Highlights
  • The Louisiana Department of Health collaborated with Well-Ahead Louisiana to implement the National DPP lifestyle change program screening, testing, and referral benchmarks for healthcare facilities.
  • The Louisiana Department of Health partnered with the University of Louisiana Monroe School of Pharmacy to deliver Collaborative Drug Therapy Management (CDTM) trainings for pharmacy sites. The state also enacted Senate Resolution 39, requiring the Board of Pharmacy to review CDTM regulations and provide recommendations for improvement.
Additional Metrics
Related Resources